跳至主要内容
临床试验/ACTRN12611001083987
ACTRN12611001083987进行中(未招募)3 期

A randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma; primary outcome is success (no treatment failure or recurrence) at 3 years.

niversity of Nottingham0 个研究点目标入组 500 人开始时间: 2011年10月19日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
o limit 至 o limit(—)
性别
All

入选标准

  • People with low risk superficial or nodular basal cell carcinoma (histologically proven basal cell carcinoma)

排除标准

  • Genetic/nevoid conditions e.g. Gorlin's syndrome.
  • Morphoeic (microinfiltrative) trial lesion as diagnosed clinically.
  • Allergy to any of the interventions.
  • Involvement in a trial of another experimental intervention.
  • Life threatening disease.
  • Patients with bleeding disorders.
  • Patients not available for follow up for 3 yrs.
  • Pregnant, intention to become pregnant during treatment phase of the trial, or breastfeeding.

研究者

发起方
niversity of Nottingham

相似试验

A randomised controlled trial of excisional surgery... | 临床试验